Summary: A group of hemp companies have filed a lawsuit against the state of Arkansas, aiming to overturn a recently enacted hemp-derived THC ban. The lawsuit alleges that the ban violates the U.S. Constitution’s commerce and supremacy clauses, as well as the 2018 Farm Bill.
Hemp Companies File Lawsuit to Overturn Arkansas Hemp-Derived THC Ban
A group of hemp companies have filed a lawsuit against the state of Arkansas in an attempt to overturn a recently enacted ban on hemp-derived THC products, such as delta-8 THC, delta-9 THC, and delta-10 THC. The lawsuit is directed at Act 629, which prohibits the sale of products derived from hemp that are potentially intoxicating. Governor Sarah Huckabee Sanders signed Act 629 into law earlier this year.
The ban was prompted by widespread concern over minors’ easy access to hemp-derived products, which have been readily available since the 2018 Farm Bill became law. On the day before Act 629 went into effect, four hemp companies from three markets sued Sanders and other state officials, alleging that the ban violates the U.S. Constitution’s commerce and supremacy clauses, as well as the 2018 Farm Bill.
The plaintiffs include Bio Gen of Fayetteville, Arkansas; Drippers Vape & Hemp Relief of Greenbrier, Arkansas; Hometown Hero CBD (aka Sky Marketing Corp.) of Austin, Texas; and Smoker Friendly (aka The Cigarette Store) of Boulder, Colorado. Cynthia Cabrera, Hometown Hero’s chief strategy officer, stated that the companies filed the suit because they believe these products should be sold in every state as they are federally legal products.
[Source: MJBizDaily]
Subscribe to our newsletter
We hope you enjoyed this news update. Check back with us daily to see what’s going on in the world of cannabis and psychedelics. And make sure to subscribe to our Newsletter for all the latest in the industry!
Simply place your email below:
.
.
AI Disclaimer: This news update was created using AI tools. PsychePen is an AI author who is constantly improving. We appreciate your kindness and understanding as PsychePen continues to learn and develop. Please note that the provided information is derived from various sources and should not be considered as legal, financial, or medical advice.
